INTRODUCTION
Lung cancer is the leading cause of cancer death in the world. 80% of all lung cancers are non-small cell lung carcinoma (NSCLC), which are often treated with thoracic radiotherapy (RT); however, the lung is a very radiosensitive organ and radiation-induced lung injury (RILI) is a common side effect. The incidence of RILI is reported to be 37%, and of this population 20% are diagnosed with moderate to severe RILI (1) . Coughing, fever and dyspnea have also been reported in 5-50% of the RILI population (2) . RILI can lead to temporary or permanent loss of lung function and in extreme cases death (3) .
Clinical assessment and management of RILI utilizes both pulmonary function tests (PFTs) (e.g. spirometry, blood gases) and imaging techniques. Persistence of hypoxia as measured by the partial pressure of oxygen in arterial blood (p a O 2 ) has been reported post radiation therapy (4, 5) , and recent studies suggest that it may further exacerbate lung injury (2) . However, PFTs are whole-lung measurements and cannot identify regional deficiencies in lung function, which presumably reduces the sensitivity of PFTs to early injury. Imaging of RILI is typically performed using planar X-ray and computed tomography (CT). Although CT changes have been observed before the onset of clinical RILI (6) , these anatomical changes (e.g. lung density) often do not occur before clinical symptoms manifest (7, 8) . In a previous study, RILI was detected using CT in roughly 75% of patients undergoing RT, but not detected earlier than four weeks post RT (9) . CT imaging of late-stage RILI is currently the gold standard for discerning fibrosis from lung tumor recurrence; however, it is often too late (several months) to effect any change in therapy to mitigate RILI. An imaging method sensitive to early (weeks) changes associated with RILI (i.e. radiation pneumonitis, RP) would be valuable to identify radiosensitive individuals and adjust therapy accordingly.
X-ray imaging methods are insensitive to functional changes associated with early RILI such as deficits in gas exchange, perfusion and ventilation, which are expected to occur well before anatomical changes. For this reason, nuclear medicine imaging techniques such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET) can be used when functional lung information such as perfusion is required (10) . Functional imaging with SPECT can provide ventilation and perfusion maps of the lung post injection of technetium-99 m (11, 12) . Studies have demonstrated a dosedependent reduction in perfusion and ventilation at 3-4 months post radiation therapy (13, 14) . However, correlations between these metrics and whole-lung function assessed by pulmonary function testing (i.e. forced expiratory volume in 1 s and diffusing capacity for carbon monoxide) are weak and additional work is required to assess regional injury (10) . Additionally, SPECT imaging is limited in spatial resolution, lacks specificity and provides~3 mSv of extra whole-body radiation dose to the patient (15) , which is approximately three times the annual background dose (~1 mSv) and 60% of the annual radiation worker limit(~5 mSv). PET imaging with fluorodeoxyglucose ( 18 F-FDG) has shown increased uptake of 18 F-FDG associated with RILI in lung cancer patients (16) ; however, the technique is heavily dependent on tissue uptake of 18 F-FDG and is susceptible to a high false positive rate (17) . In particular, high uptake of 18 F-FDG is associated with both inflammation and tumor growth, and no clear separation of RILI and cancer has been demonstrated (18, 19) . As with SPECT, PET requires an acquisition time of approximately an hour and also incurs additional radiation dose to the patient (~15% of the annual radiation worker limit).
In contrast to X-ray and nuclear medicine imaging methods, MRI provides an approach for probing lung anatomy and function without the use of ionizing radiation, which may be particularly well suited for tracking the progression and regression of the early stage of RILI. Conventional MRI (i.e. proton) approaches aimed at detection of RILI have been performed previously through the measurement of regional perfusion (20) and the T 2 relaxation times of lung tissues (21) . However, proton MRI is challenging in the lung due to low proton signal, as it contains only approximately 20% soft tissue. This low signal is further diminished by the presence of microscopic magnetic field non-uniformities arising from susceptibility differences at the gas/tissue interface. Furthermore, respiratory motion can be problematic, leading to image blurring and other artifacts.
The issue of low MRI signal in the lung has recently been addressed by the advent of spin exchange optical pumping (i.e. hyperpolarization) techniques, which can boost the signal of certain inhaled noble gases ( 3 He and 129 Xe) by up to five orders of magnitude (22) . High spatial resolution spectroscopic imaging can be achieved with hyperpolarized gas MRI, and it provides a wide palette of anatomical and functional biomarkers, which can potentially map RILI progression and treatment response including ventilation (23) , perfusion (24) , and gas exchange (25) . In addition, a truly unique morphological lung measurement is possible using hyperpolarized gas MRI, namely the apparent diffusion coefficient (ADC), a surrogate for alveolar size. Some of these measures have already been investigated in patients with chronic obstructive pulmonary disease (COPD) (26) (27) (28) , asthma (29) and cystic fibrosis (30, 31) , as well as in animal models of lung disease (20, 24, 25, 27, (32) (33) (34) (35) (36) . More recently, 13 C has been added to the family of hyperpolarized nuclei available for use with MRI (37) . The polarization of 13 C nuclei can be greatly enhanced in the solid state using dynamic nuclear polarization (DNP), in which certain 13 C-enriched endogenous compounds may be prepared with liquid-state polarizations exceeding 20% as injectable probes of cellular metabolism. In vivo MR spectroscopic imaging of the metabolites of hyperpolarized contrast agents such as [1-13 C]pyruvate and [1-13 C-]lactate have been used to differentiate tissue undergoing anaerobic glycolysis, most notably associated with cancer and hypoxia (38) (39) (40) (41) .
This article reviews the current state of hyperpolarized MRI in the context of a mechanistic picture of RILI pathogenesis. Several important experimental hyperpolarized MRI approaches are presented, and results of anatomical and functional hyperpolarized 129 Xe MRI of RILI are summarized, including ADC mapping, morphometry and gas exchange measurement using a whole-thorax model of RILI in the rat. Next, metabolic MRI studies using hyperpolarized [1 13 C] pyruvate for early detection of RILI in a rat model are described. Finally, limitations and future directions of hyperpolarized MRI are presented, and extensions to clinical applications are discussed.
Pathogenesis of RILI
Following acute radiation damage, the inflammatory cascade associated with RILI ( Fig. 1 ) consists of two main phases: (i) an early phase characterized by RP and (ii) a later phase characterized by tissue remodeling and fibrosis (42, 43) , though one can occur without the other. The RP stage, typically lasting days to several weeks, is initiated by an overwhelming inflammatory response believed to be triggered by cytokines (e.g. interleukin 6, tumor necrosis factor alpha) released by activated resident leukocytes (i.e. macrophages), signaling migrating leukocytes (e.g. macrophages and neutrophils) to adhere to and penetrate the injured epithelial and endothelial layers. If injury to the alveolar epithelium is significant and/or unrepaired, chronic fibrosis will result (months). This can lead to progressive lung function loss and ultimate organ failure, affecting about 50% of individuals with severe lung injury. The occurrence of RP is characterized by the onset of inflammation, which is highly dependent on the release of inflammatory cytokines (44) . Immunohistochemical analysis of RP in animal models reveals underlying cellular changes including increases in alveolar macrophages, inflammatory cytokines and type II pneumocytes (45, 46) . These changes are observed both within and outside the region of conformal RT (47, 48) , and persist up to four weeks post irradiation in rats (49) .
Detection of RILI and its severity in the RP stage, before irreversible fibrosis, could potentially alter the course of RT fractionation and/or initiate adjuvant therapy earlier to mitigate RILI and improve patient outcome. A number of microanatomical and functional changes accompanying RP may be useful targets for hyperpolarized MRI methods. The RP phase is marked by loss of alveolar function due to flooding (i.e. edema) from epithelial damage, thickening of alveolar and capillary walls and inactivation of surfactant leading to reductions in ventilation and perfusion, ultimately leading to hypoxia/ischemia, compromised gas exchange and reduced lung compliance (50) . ADC of hyperpolarized 129 Xe MRI may be employed to detect the reduction of alveolar air space associated with RP, while measurement of the time for 129 Xe to diffuse through the alveolar wall can enable the detection of the thickening of alveolar walls due to RP.
From the metabolic standpoint, hypoxia in lung tissue plays a role in mediation of the inflammatory process in RP (51) . Decreased arterial partial pressure of oxygen (p a O 2 ), an indicator of hypoxia (52), has been reported following RT (53, 4) . Recent observations from lung cancer patients post irradiation suggest a strong correlation between dynamic changes in serum markers (i.e. cluster of differentiation 35) and onset of RP (54) , and between the amount of exhaled nitric oxide (NO) and onset of RP (55) . Hypoxia during RP is expected to increase the level of anaerobic glycolysis to meet the constant energy needs of the lung tissue, which in turn leads to a higher level of lactate. Therefore, MRI using hyperpolarized [1-13 C]pyruvate and [1-13 C] lactate may be particularly sensitive to RP.
APPLICATION OF HYPERPOLARIZED MRI TO RILI
Hyperpolarized noble gases for anatomical and functional MRI of RILI Hyperpolarized 3 He gas has been used for studies of RILI, in both clinical subjects and animal models. These include identification of ventilation defect progression, stasis and decline correlated with the presence of RILI measured longitudinally (1, 56, 52, 57) as well as approaches to register 3 He images with CT images to enable computation of RT plans for functional lung avoidance (58, 59) . However, the presumption that ventilation defects reflect functional deficits (i.e. non-ventilated lung) due to RILI may not be strictly true in the presence of tumor and other airway obstruction, commonly found in COPD, a co-morbidity of lung cancer. In this regard, mapping of ADC may be particularly useful for identifying microstructural changes associated with RP in ventilated lung, as alveolar gas space decreases due to inflammation are opposite to the alveolar enlargement expected in emphysema, a common component of COPD. Decreases in 3 He ADC corresponding to regions of fibrosis related to radiation exposure have been reported in a rat model of RILI consisting of fractionated delivery of 40 Gy to the right lung (33) . 3 He ADC mapping has also been conducted in lung cancer patient populations (1) .
While the scarcity of 3 He will likely limit its wide-spread clinical application, 129 Xe is more abundant and less expensive and has the additional advantage of relatively high tissue solubility permitting mapping of gas exchange and perfusion. Although 129 Xe development has lagged in comparison to 3 He, recent technical advances significantly improving the achievable levels of polarization in clinically relevant quantities (60,61) have renewed interest in 129 Xe for lung imaging, specifically mapping of microanatomical changes using ADC, as well as imaging of gas exchange. With a self-diffusion coefficient approximately onetenth that of 3 He, 129 Xe gas provides diffusion length scales that better match the alveolar size (~100-300 μm) at the diffusion times (several milliseconds) typical of clinical MRI systems, and therefore may be preferable for measurement of alveolar damage due to RILI.
Microanatomical MRI of RP: 129 Xe ADC mapping and morphometry
In our laboratory, we have developed a model of RP using thoracic irradiation of the rat lung. This animal model permits the design of cohort studies to look at the longitudinal effects of RP in a controlled setting particularly the early RP stage (typically at 2 weeks and 6 weeks post-irradiation), which is not generally possible in a human population, where RP can remain undetectable using standard techniques (described above). In our set-up, Sprague Dawley rats receive thoracic irradiation using a 60 Co source with an average dose rate of 2 Gy/min for a total dose of 14 Gy (62). Age-matched Sprague Dawley rats that are not exposed to radiation serve as healthy controls. Following imaging, the lungs are fixed by intratracheal infusion of 8 mL of 10% neutral-buffered formalin and allowed a fixation period of at least 24 h. The fixed lung specimens are then embedded in paraffin wax, cut into 5 μm thick tissue sections and stained with hematoxylin and eosin. Figure 2 shows representative sections of a healthy rat lung and a rat lung 2 weeks post irradiation.
For ADC mapping, a two-dimensional diffusion-weighted fast gradient echo is typically employed (35) with sufficient diffusion time (a few milliseconds) to ensure diffusion lengths are matched to alveolar dimensions. A single diffusion gradient sensitization (i.e. b-value) is chosen to achieve adequate contrast (typically 10-20 s/cm 2 ); however, a range of b-values can also be applied to investigate diffusional anisotropy. Diffusion in the terminal airways of the lung can be described by two anisotropic diffusion coefficients: (i) the longitudinal diffusion coefficient (D L ), describing diffusion along the length of the airway, and (ii) the transverse diffusion coefficient (D T ), describing diffusion perpendicular to the length of the airway (63) . Figure 3 terminal airway is represented by a cylinder (inner radius r, outer radius R) containing alveoli of size L and sleeve depth h. Morphometric maps of the terminal airway can be computed from D L and D T maps using the phenomenological model of Sukstanskii and Yablonskiy (63) . Figure 4 shows 2D coronal projection xenon density images along with the corresponding morphometric maps for r and h computed using the cylinder model (64) , for both a representative healthy rat ( Fig. 4(a) ) and a rat two weeks post irradiation ( Fig. 4(b) ). In Figure 4(a) , (b), the major airways were removed from the diffusion maps prior to morphometric analysis. The morphometric maps show significant decreases in r and increases in h for the irradiated rat compared with the healthy rat consistent with inflammation, whereas little difference is seen in the density-weighted image. This suggests that underlying RP changes due to inflammation are not affecting ventilation at this relatively early stage of RILI. Based on a cohort of healthy (n = 3) and a cohort of irradiated rats (n = 3), the mean r values decreased from 136 (±19) μm to 102 (±30) μm (p = 0.029) respectively and the mean h values increased from 46 (±17) μm to 71 (±27) μm (p = 0.008) respectively.
Functional MRI of RILI: dissolved-phase 129 Xe MRI and measurement of gas exchange 129 Xe gas, equilibrating in the lungs, consists of a gas resonance as well as several distinct dissolved-phase resonances, corresponding to various tissue compartments including lung parenchyma and red blood cells (RBCs), among others (65) . Spectroscopy of 129 129 Xe lung images and corresponding morphometry (r, h) maps for (a) healthy rat lungs and (b) rat lungs two weeks following irradiation. Note that the Several dynamic 129 Xe spectroscopic approaches have been developed, in both humans and animals, based on xenon transfer between the gas phase and the dissolved phases, including chemically selective saturation recovery (CSSR) (69), xenon transfer contrast (XTC) (70) , xenon alveolar capillary transfer (32), multiple exchange time xenon polarization transfer contrast (71) and, more recently, the model of xenon transfer exchange (72, 73) . The application of 129 Xe XTC imaging techniques to the detection of RILI was first reported by Ruppert et al. (74) , where reductions in XTC signal were reported at four months post irradiation in a rabbit model of RILI involving three fractions of 20 Gy delivered to the right lung. In that work, it was suggested that this was a reflection of reduced gas exchange, consistent with blood vessel damage confirmed histologically.
In contrast to XTC, CSSR resolves the tissue and RBC dissolved phases directly as a function of a characteristic delay time τ, allowing measurement of compartment-specific gas transfer time constants T Tr_tissue and T Tr_RBC , which may each be differentially sensitive to gas exchange and perfusion. Figure 5 shows a representative set of CSSR data we have obtained from the lungs of a healthy rat for both the tissue and the RBC compartments as well as the gas-phase resonance for comparison. Theoretical models of xenon exchange measured with CSSR have been explored in humans (75) and rat models of inflammation using lipopolysaccharide (24) and bleomycin (32) . Xenon diffusing capacity analogous to the diffusing capacity of carbon monoxide can also be measured using CSSR, and has been explored for assessment of inflammation due to fungal infection (25) .
Our laboratory has used dynamic CSSR spectroscopy to investigate RP in the 60 Co irradiation rat model described above, at two and six weeks post-irradiation (76) . Figure 6 shows representative CSSR curves obtained from a representative healthy rat ( Fig. 6(a) ) and a two-week irradiated rat ( Fig. 6(b) ) (76) . The solid curves are the best fit to the data using the theoretical model of Mansson et al. (24) , yielding whole-lung estimates of T Tr_tissue and T Tr_RBC . Figure 7 (a) presents the mean transfer times obtained for the age-matched healthy cohort as well as the irradiated cohorts at two weeks and six weeks post irradiation. Post hoc t-tests revealed that T Tr_tissue in the twoweek group was statistically significantly elevated compared with the healthy and six-week groups (p < 0.05) (76) . This increase in transfer time was attributed to gas exchange reductions caused by alveolar gas barrier thickening, a consequence of inflammation in RP. These increases in gas transfer times were also shown to be consistent with p a O 2 reductions ( Fig. 7(b) ) and alveolar gas barrier thickening ( Fig. 2(b) ) and/or surface to volume ratio reductions measured using blood gas analysis and histology respectively in other cohorts similarly irradiated (76) . It is likely that such whole-lung estimates of gas exchange will benefit in the future from the ability to spatially resolve changes that may be occurring regionally in the lung.
Hyperpolarized 13 C for metabolic MRI of RILI
To our knowledge, the first use of hyperpolarized 13 C in the lung was undertaken by Ishii et al., where 13 C-enriched hydroxyethylpropionate was used to image pulmonary blood flow in the lungs of a healthy pig (77) . For metabolic imaging, the pyruvate molecule enriched with 13 C at the C-1 position can be polarized to a high degree and the conversions of [1-13 C]pyruvate to its metabolic products, [1-13 C]lactate, 13 C-bicarbonate and [1-13 C]alanine, have been observed in vivo for detection of cancer in animal models (40, 78) , and humans (79) . Specifically, the ratio of [1-13 C]lactate signal to [1-13 C]pyruvate signal (lac/pyr) has been shown to reflect the presence of anaerobic glycolysis in tumors, a surrogate for hypoxia (79) . [1-13 C] pyruvate has also been used to detect reductions in reactive oxygen species following irradiation of anaplastic thyroid carcinoma xenografts in mice (80) .
Although the application of hyperpolarized [1-13 C]pyruvate imaging to the lung presents significant challenges mainly due to the low tissue concentrations afforded by intravenous injection, [1-13 C]lactate labeling following injection of [1-13 C]pyruvate has been used to investigate lung ischemia in the isolated perfused rat lung ex vivo (81) . The ex vivo perfused organ approach is a useful model system to investigate the time course of hyperpolarized [1-13 C]pyruvate and its products in the lung with the opportunity to manipulate the metabolic environment (e.g. hypoxia) in a controlled way. In that work, a several-fold increase in lactate labeling was observed during conditions of ischemia compared with the base-line (i.e. normoxic) state. This increase in lactate labeling was seen to revert to baseline upon reperfusion and was consistent with changes in high-energy phosphate metabolism measured using 31 P NMR (81) .
The first in vivo hyperpolarized 13 C-pyruvate investigation of the lung, and of RILI, was reported by Thind et al. (62) . In that work, lac/pyr was observed to increase by 110% (p < 0.01), 57% (p < 0.02) and 107% (p < 0.01) respectively in the entire thorax, lung and heart tissues of rats two weeks post whole-thorax irradiation (14 Gy, as described above) compared with healthy age-matched rats. This was consistent with RP confirmed using cell micrographs of bronchioalveolar lavage specimens and decreases in arterial oxygen partial pressure (p a O 2 ), indicative of hypoxia. This was not seen in tissues outside the field of irradiation (i.e. kidneys), nor were changes reported in blood lactate levels, confirming the injury was confined to the thorax (62) .
More recently, our group has used hyperpolarized [1-13 C]pyruvate to investigate the regional and longitudinal metabolic effects of RILI using an in vivo model of RILI involving conformal irradiation of the rat (82) . In this study, the right medial lobe of the lungs of 12 Sprague Dawley rats were irradiated in two fractions with a total dose of 18.5 Gy using a modified μCT/RT system (83) . Fluoroscopy was employed to set the irradiation field to completely shield the beating heart. 13 C-labelled pyruvic acid was hyperpolarized using a commercial DNP system (HyperSense, Oxford Instruments) and chemical shift imaging (CSI) performed at 3T (GEHC Discovery MR750, Waukesha, WI) following tail vein injection (62). Regional lactate and pyruvate data were acquired from three irradiated and three age-matched healthy rats at 5, 10, 15 and 25 days post-RT. Arterial blood was collected from each animal prior to the [1-13 C]pyruvate injection and was analyzed for blood lactate concentration and arterial oxygen concentration (p a O 2 ). Macrophage count was computed from histology of all rat lungs. Figure 8 shows the slab localized in the rat as a transverse plane encoded with CSI voxels overlaid on a standard proton T 1 -weighted image. Four voxels were selected from the left lung, right lung and heart regions from each animal and were analyzed for lac/pyr. Arterial blood was collected from each animal prior to the pyruvate injection and was analyzed for blood lactate concentration and arterial oxygen concentration (p a O 2 ). Following imaging, the rat lungs were removed, fixed, sectioned and stained for histological analysis. Figure 9 shows the corresponding lac/pyr values for the right lung and heart regions shown in Figure 8 at all time points. Statistically significant increases in lac/pyr (p < 0.05) in the irradiated (right) lung were observed compared with healthy rats at days 5, 10, 15 and 25-post irradiation (82) . No increase in lac/pyr was observed in the hearts of the irradiated cohort compared with the hearts of the healthy cohorts. Neither blood lactate concentration nor p a O 2 showed a significant change between the irradiated and the healthy cohorts. Macrophage counts in both right and left lung were elevated for the irradiated cohort compared with the healthy cohort (82), consistent with the RP inflammatory phase of early RILI (84) .
Interestingly, a significant increase in lac/pyr was observed in both the right and left lungs of the irradiated cohort compared with the healthy cohort for all time points. Macrophage counts from the right and left lungs of both the healthy rats and the irradiated rats appeared to be highly correlated to the lac/pyr values at all time points, with a Spearman correlation coefficient of 0.86 (p < 0.01) for the right lung and 0.85 (p < 0.01) for the left lung ( Fig. 10) . No statistically significant changes were observed in lac/pyr in the heart or in blood lactate levels or p a O 2 between healthy and irradiated animals at any time point. Furthermore, Figure 7 . (a) Mean T Tr values for lung tissue and RBCs measured in a healthy rat cohort and an irradiated rat cohort two and six weeks following irradiation. (b) Corresponding mean arterial blood oxygen partial pressure measured in similar cohorts. A statistically significant increase in T Tr (* p < 0.05) was seen for lung tissue in the irradiated cohort at two weeks compared with the healthy cohort, consistent with arterial blood oxygenation changes. 
DISCUSSION AND FUTURE DIRECTIONS
RILI is an important limiting factor in the RT treatment of thoracic cancers, most notably NSCLC, responsible for 80% of lung cancer. Strategies to mitigate RILI, which subsequently results in irreversible fibrosis, may benefit from early detection of RP, where the effects are most readily treated. MRI with hyperpolarized nuclei, specifically following inhalation of 129 Xe and injection of [1-13 C]pyruvate, may offer a useful approach for detection of RP. To the extent that these hyperpolarized nuclei can be delivered to the injured portions of the lung, these approaches can offer valuable insight into the microanatomical, functional and metabolic changes accompanying RILI. Irradiation of animal (i.e. rodent) lungs, both whole-thorax as well as conformal delivery, can be useful for imaging RILI in a controlled fashion, particularly to study longitudinal effects and correlate with histological changes. MRI of the apparent diffusion of hyperpolarized noble gases is a powerful tool for quantifying regional microanatomical changes associated with RILI. For the diffusion times and gas mixtures typically used in hyperpolarized 129 Xe MRI, the diffusion lengths are ideally suited for probing changes in the morphometry of the terminal airways and alveoli associated with RILI. In particular, alveolar size and internal radius of the terminal airway are observed to decrease and alveolar sleeve depth is observed to increase due to inflammation associated with RP. These changes are qualitatively consistent with histology and will be reported in detail in a future publication. The use of morphometry to investigate longitudinal changes, especially from conformal irradiation and fractionated delivery similar to that used clinically, and correlation with quantitative histology, will likely be fruitful areas of future research. MRI morphometry is also expected to benefit from emerging 3D histology approaches in order to validate microanatomical changes which are inherently 3D in nature.
The dual capability of hyperpolarized 129 Xe to probe functional as well as anatomical changes associated with RILI is expected to be particularly beneficial for detection of RP, since functional deficits (e.g. gas exchange and perfusion) are expected to precede morphological changes. The ability to resolve 129 Xe dissolved in both the lung tissue compartment and blood compartment (i.e. RBCs) and measure the relative dynamics of the 129 Xe signal from these compartments, particularly following selective RF pulse strategies (e.g. CSSR), allows measurement of gas exchange reductions associated with RP inflammation as early as two weeks. The use of the 129 Xe RBC signal as an indication of blood vessel destruction expected to accompany early radiation damage could provide valuable mechanistic insight. Figure 6 suggests that decreases in the ratio of 129 Xe signal from the RBC phase relative to the tissue phase may occur, possibly associated with gas exchange impairment and/or loss of vasculature. Further work is needed in order to delineate the interplay of these mechanistic processes and this will likely be aided by the use of more sophisticated animal experiments, higher nuclear polarizations and spectroscopic imaging techniques (e.g. Dixon-based techniques). For example, the effects of total dose, conformation, dose rate and fractionation scheme could be studied. The data could be collected for a longer time span (e.g. zero days to 20 weeks post irradiation procedure) to understand the effects of the underlying injury on gas exchange.
Animal studies should also advance our understanding of the metabolic changes associated with RILI, specifically the origin of the [1-13 C]lactate changes. This would include correlation of lac/pyr ratio and identification of the type of proliferating leukocyte. Comparison of lac/pyr data with histology following hypoxia staining as well as leukocyte counting could help decode the origin of lac/pyr changes in RP. Additional studies could be performed to profile the inflammatory cytokines, other leukocytes (e.g. neutrophils), type II pneumocytes, endothelial cells and fibroblasts in a similar manner to test the relationship between lac/pyr and the evolution of these physiological parameters as a function of time and following administration of radioprotector chemical species such as superoxide dismutase post-irradiation (49) . The role of the contralateral lung in RILI response is also worthy of further investigation.
Though the application of hyperpolarized MRI is well developed in animal models, particularly [1-13 C]pyruvate, clinical studies are lagging mainly due to the limited output and availability of this technology. This is expected to change with the emergence of turn-key polarizers capable of providing the necessary volumes, polarizations and quality suitable for human use. The clinical translation of these methods is unclear, but integration of hyperpolarized MRI into the therapy plan would likely be most useful prior to and within the first few weeks of RT delivery. Detection of early RP using hyperpolarized [1-13 C]pyruvate MRI could allow monitoring of ongoing radiation therapy of breast cancer, lung cancer and other thoracic cancers that may be susceptible to RILI. The information could be used as feedback for modification of the radiation therapy (or chemotherapy) plan or to determine whether anti-inflammatory drugs would help (e.g. corticosteroids). Since every patient may have a slightly different physiological make-up, [1-13 C]pyruvate MRI could assist with personalized treatment, where the metabolism of each patient could be recorded and used in the ongoing therapeutic intervention. The non-ionizing nature of MRI also permits repeated scans for continuous monitoring of a patient, which may not be possible with PET or CT. Continuous monitoring may be important to track the evolution of both the tumor response and RP in cancer patients. While onset of RP leads to higher lac/pyr post radiation therapy in the non-cancerous injured lung, lung cancer cells may begin to demonstrate lower lac/pyr post therapeutic intervention, as demonstrated in the literature with other cancer cell lines (85) . In addition, hyperpolarized 13 C-bicarbonate might also be useful to map pH of tumors undergoing radiation therapy, as pH plays a vital role in tumor progression and therapy (86) .
In summary, hyperpolarized MRI techniques, most notably 129 Xe gas and [1-13 C]pyruvate, are very promising approaches for detection of anatomical, functional and metabolic changes associated with RILI. Early and regional detection of RP associated with RILI using these emerging imaging techniques may play a significant role in the personalization of ongoing RT and adjuvant therapy, thereby improving outcomes.
